Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported its Q2 earnings results on Tuesday, May 10, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Arrowhead Pharmaceuticals beat estimated earnings by 612.5%, reporting an EPS of $0.41 versus an estimate of $-0.08.
Revenue was up $118.99 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.15 which was followed by a 6.92% drop in the share price the next day.
Here's a look at Arrowhead Pharmaceuticals's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.45 | -0.10 | -0.20 | -0.13 |
| EPS Actual | -0.60 | -0.61 | -0.29 | -0.26 |
| Revenue Estimate | 51.04M | 56.77M | 37.52M | 37.70M |
| Revenue Actual | 27.44M | 38.28M | 45.89M | 32.81M |
To track all earnings releases for Arrowhead Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
